HALD4
MCID: HYP708
MIFTS: 22

Hyperaldosteronism, Familial, Type Iv (HALD4)

Categories: Blood diseases, Cardiovascular diseases, Endocrine diseases, Genetic diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Hyperaldosteronism, Familial, Type Iv

MalaCards integrated aliases for Hyperaldosteronism, Familial, Type Iv:

Name: Hyperaldosteronism, Familial, Type Iv 57 75 29 6 40
Hald4 57 75
Fh Iv 57 75
Aldosteronism, Primary, and Hypertension 57
Primary Aldosteronism and Hypertension 75
Hyperaldosteronism, Familial, 4 75

Characteristics:

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
incomplete penetrance in some families
onset of hypertension in the first decade of life


HPO:

32
hyperaldosteronism, familial, type iv:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 57 617027
MeSH 44 D006929
SNOMED-CT via HPO 69 263681008 24184005 38341003

Summaries for Hyperaldosteronism, Familial, Type Iv

UniProtKB/Swiss-Prot : 75 Hyperaldosteronism, familial, 4: A form of familial hyperaldosteronism, a disorder characterized by hypertension, elevated aldosterone levels despite low plasma renin activity, and abnormal adrenal steroid production. There is significant phenotypic heterogeneity, and some individuals never develop hypertension.

MalaCards based summary : Hyperaldosteronism, Familial, Type Iv, is also known as hald4. An important gene associated with Hyperaldosteronism, Familial, Type Iv is CACNA1H (Calcium Voltage-Gated Channel Subunit Alpha1 H). Affiliated tissues include adrenal gland, and related phenotype is hypertension.

Description from OMIM: 617027

Related Diseases for Hyperaldosteronism, Familial, Type Iv

Symptoms & Phenotypes for Hyperaldosteronism, Familial, Type Iv

Symptoms via clinical synopsis from OMIM:

57
Cardiovascular Vascular:
hypertension

Laboratory Abnormalities:
elevated aldosterone levels
low renin levels

Endocrine Features:
microscopic hyperplasia of adrenal gland glomerulosa


Clinical features from OMIM:

617027

Human phenotypes related to Hyperaldosteronism, Familial, Type Iv:

32
# Description HPO Frequency HPO Source Accession
1 hypertension 32 HP:0000822

Drugs & Therapeutics for Hyperaldosteronism, Familial, Type Iv

Search Clinical Trials , NIH Clinical Center for Hyperaldosteronism, Familial, Type Iv

Genetic Tests for Hyperaldosteronism, Familial, Type Iv

Genetic tests related to Hyperaldosteronism, Familial, Type Iv:

# Genetic test Affiliating Genes
1 Hyperaldosteronism, Familial, Type Iv 29 CACNA1H

Anatomical Context for Hyperaldosteronism, Familial, Type Iv

MalaCards organs/tissues related to Hyperaldosteronism, Familial, Type Iv:

41
Adrenal Gland

Publications for Hyperaldosteronism, Familial, Type Iv

Variations for Hyperaldosteronism, Familial, Type Iv

UniProtKB/Swiss-Prot genetic disease variations for Hyperaldosteronism, Familial, Type Iv:

75
# Symbol AA change Variation ID SNP ID
1 CACNA1H p.Ser196Leu VAR_077064 rs780596901
2 CACNA1H p.Met1549Ile VAR_077065
3 CACNA1H p.Met1549Val VAR_077066 rs786205050
4 CACNA1H p.Pro2083Leu VAR_077068 rs759924732

ClinVar genetic disease variations for Hyperaldosteronism, Familial, Type Iv:

6 (show top 50) (show all 836)
# Gene Variation Type Significance SNP ID Assembly Location
1 CACNA1H NM_021098.2(CACNA1H): c.1853C> T (p.Pro618Leu) single nucleotide variant risk factor rs60734921 GRCh37 Chromosome 16, 1252303: 1252303
2 CACNA1H NM_021098.2(CACNA1H): c.1853C> T (p.Pro618Leu) single nucleotide variant risk factor rs60734921 GRCh38 Chromosome 16, 1202303: 1202303
3 CACNA1H NM_021098.2(CACNA1H): c.2626G> A (p.Ala876Thr) single nucleotide variant Benign rs58173258 GRCh37 Chromosome 16, 1256126: 1256126
4 CACNA1H NM_021098.2(CACNA1H): c.2626G> A (p.Ala876Thr) single nucleotide variant Benign rs58173258 GRCh38 Chromosome 16, 1206126: 1206126
5 CACNA1H NM_021098.2(CACNA1H): c.1664C> T (p.Ala555Val) single nucleotide variant Benign rs9924241 GRCh37 Chromosome 16, 1252114: 1252114
6 CACNA1H NM_021098.2(CACNA1H): c.1664C> T (p.Ala555Val) single nucleotide variant Benign rs9924241 GRCh38 Chromosome 16, 1202114: 1202114
7 CACNA1H NM_021098.2(CACNA1H): c.1844C> T (p.Thr615Met) single nucleotide variant Conflicting interpretations of pathogenicity rs368976749 GRCh37 Chromosome 16, 1252294: 1252294
8 CACNA1H NM_021098.2(CACNA1H): c.1844C> T (p.Thr615Met) single nucleotide variant Conflicting interpretations of pathogenicity rs368976749 GRCh38 Chromosome 16, 1202294: 1202294
9 CACNA1H NM_021098.2(CACNA1H): c.2265C> T (p.Gly755=) single nucleotide variant Benign rs61073355 GRCh37 Chromosome 16, 1254272: 1254272
10 CACNA1H NM_021098.2(CACNA1H): c.2265C> T (p.Gly755=) single nucleotide variant Benign rs61073355 GRCh38 Chromosome 16, 1204272: 1204272
11 CACNA1H NM_021098.2(CACNA1H): c.3555G> A (p.Ala1185=) single nucleotide variant Conflicting interpretations of pathogenicity rs370039255 GRCh37 Chromosome 16, 1259223: 1259223
12 CACNA1H NM_021098.2(CACNA1H): c.3555G> A (p.Ala1185=) single nucleotide variant Conflicting interpretations of pathogenicity rs370039255 GRCh38 Chromosome 16, 1209223: 1209223
13 CACNA1H NM_021098.2(CACNA1H): c.4488G> A (p.Ser1496=) single nucleotide variant Conflicting interpretations of pathogenicity rs377112179 GRCh37 Chromosome 16, 1261727: 1261727
14 CACNA1H NM_021098.2(CACNA1H): c.4488G> A (p.Ser1496=) single nucleotide variant Conflicting interpretations of pathogenicity rs377112179 GRCh38 Chromosome 16, 1211727: 1211727
15 CACNA1H NM_021098.2(CACNA1H): c.4817C> T (p.Thr1606Met) single nucleotide variant Benign/Likely benign rs59286323 GRCh37 Chromosome 16, 1263819: 1263819
16 CACNA1H NM_021098.2(CACNA1H): c.4817C> T (p.Thr1606Met) single nucleotide variant Benign/Likely benign rs59286323 GRCh38 Chromosome 16, 1213819: 1213819
17 CACNA1H NM_021098.2(CACNA1H): c.6234C> T (p.Cys2078=) single nucleotide variant Benign rs59844753 GRCh37 Chromosome 16, 1270166: 1270166
18 CACNA1H NM_021098.2(CACNA1H): c.6234C> T (p.Cys2078=) single nucleotide variant Benign rs59844753 GRCh38 Chromosome 16, 1220166: 1220166
19 CACNA1H NM_021098.2(CACNA1H): c.5897C> T (p.Ala1966Val) single nucleotide variant Benign rs72552054 GRCh37 Chromosome 16, 1268979: 1268979
20 CACNA1H NM_021098.2(CACNA1H): c.5897C> T (p.Ala1966Val) single nucleotide variant Benign rs72552054 GRCh38 Chromosome 16, 1218979: 1218979
21 CACNA1H NM_021098.2(CACNA1H): c.4645A> G (p.Met1549Val) single nucleotide variant Pathogenic rs786205050 GRCh37 Chromosome 16, 1262024: 1262024
22 CACNA1H NM_021098.2(CACNA1H): c.4645A> G (p.Met1549Val) single nucleotide variant Pathogenic rs786205050 GRCh38 Chromosome 16, 1212024: 1212024
23 CACNA1H NM_021098.2(CACNA1H): c.3206G> A (p.Arg1069Gln) single nucleotide variant Benign/Likely benign rs57633676 GRCh37 Chromosome 16, 1258064: 1258064
24 CACNA1H NM_021098.2(CACNA1H): c.3206G> A (p.Arg1069Gln) single nucleotide variant Benign/Likely benign rs57633676 GRCh38 Chromosome 16, 1208064: 1208064
25 CACNA1H NM_021098.2(CACNA1H): c.3744+1G> A single nucleotide variant Uncertain significance rs770718464 GRCh37 Chromosome 16, 1259413: 1259413
26 CACNA1H NM_021098.2(CACNA1H): c.3744+1G> A single nucleotide variant Uncertain significance rs770718464 GRCh38 Chromosome 16, 1209413: 1209413
27 CACNA1H NM_021098.2(CACNA1H): c.2759C> T (p.Thr920Met) single nucleotide variant Benign/Likely benign rs59052554 GRCh37 Chromosome 16, 1256259: 1256259
28 CACNA1H NM_021098.2(CACNA1H): c.2759C> T (p.Thr920Met) single nucleotide variant Benign/Likely benign rs59052554 GRCh38 Chromosome 16, 1206259: 1206259
29 CACNA1H NM_021098.2(CACNA1H): c.5113G> A (p.Ala1705Thr) single nucleotide variant Benign/Likely benign rs148651456 GRCh37 Chromosome 16, 1265315: 1265315
30 CACNA1H NM_021098.2(CACNA1H): c.5113G> A (p.Ala1705Thr) single nucleotide variant Benign/Likely benign rs148651456 GRCh38 Chromosome 16, 1215315: 1215315
31 CACNA1H NM_021098.2(CACNA1H): c.3646G> A (p.Asp1216Asn) single nucleotide variant Uncertain significance rs754581272 GRCh37 Chromosome 16, 1259314: 1259314
32 CACNA1H NM_021098.2(CACNA1H): c.3646G> A (p.Asp1216Asn) single nucleotide variant Uncertain significance rs754581272 GRCh38 Chromosome 16, 1209314: 1209314
33 CACNA1H NM_021098.2(CACNA1H): c.1939G> A (p.Gly647Ser) single nucleotide variant Uncertain significance rs147702970 GRCh37 Chromosome 16, 1252389: 1252389
34 CACNA1H NM_021098.2(CACNA1H): c.1939G> A (p.Gly647Ser) single nucleotide variant Uncertain significance rs147702970 GRCh38 Chromosome 16, 1202389: 1202389
35 CACNA1H NM_021098.2(CACNA1H): c.5173+10C> T single nucleotide variant Benign/Likely benign rs72554026 GRCh37 Chromosome 16, 1265385: 1265385
36 CACNA1H NM_021098.2(CACNA1H): c.5173+10C> T single nucleotide variant Benign/Likely benign rs72554026 GRCh38 Chromosome 16, 1215385: 1215385
37 CACNA1H NM_021098.2(CACNA1H): c.546-10C> T single nucleotide variant Benign rs35509671 GRCh38 Chromosome 16, 1195916: 1195916
38 CACNA1H NM_021098.2(CACNA1H): c.546-10C> T single nucleotide variant Benign rs35509671 GRCh37 Chromosome 16, 1245916: 1245916
39 CACNA1H NM_021098.2(CACNA1H): c.3439A> G (p.Ser1147Gly) single nucleotide variant Benign rs780122141 GRCh37 Chromosome 16, 1259107: 1259107
40 CACNA1H NM_021098.2(CACNA1H): c.3439A> G (p.Ser1147Gly) single nucleotide variant Benign rs780122141 GRCh38 Chromosome 16, 1209107: 1209107
41 CACNA1H NM_021098.2(CACNA1H): c.4120G> A (p.Val1374Met) single nucleotide variant Uncertain significance rs201855332 GRCh38 Chromosome 16, 1210868: 1210868
42 CACNA1H NM_021098.2(CACNA1H): c.4120G> A (p.Val1374Met) single nucleotide variant Uncertain significance rs201855332 GRCh37 Chromosome 16, 1260868: 1260868
43 CACNA1H NM_021098.2(CACNA1H): c.5921A> G (p.Glu1974Gly) single nucleotide variant Benign rs3751886 GRCh38 Chromosome 16, 1219003: 1219003
44 CACNA1H NM_021098.2(CACNA1H): c.5921A> G (p.Glu1974Gly) single nucleotide variant Benign rs3751886 GRCh37 Chromosome 16, 1269003: 1269003
45 CACNA1H NM_021098.2(CACNA1H): c.108G> C (p.Pro36=) single nucleotide variant Likely benign rs28365126 GRCh37 Chromosome 16, 1203845: 1203845
46 CACNA1H NM_021098.2(CACNA1H): c.108G> C (p.Pro36=) single nucleotide variant Likely benign rs28365126 GRCh38 Chromosome 16, 1153845: 1153845
47 CACNA1H NM_021098.2(CACNA1H): c.366C> G (p.Pro122=) single nucleotide variant Likely benign rs372041705 GRCh37 Chromosome 16, 1245038: 1245038
48 CACNA1H NM_021098.2(CACNA1H): c.366C> G (p.Pro122=) single nucleotide variant Likely benign rs372041705 GRCh38 Chromosome 16, 1195038: 1195038
49 CACNA1H NM_021098.2(CACNA1H): c.390C> T (p.Ser130=) single nucleotide variant Benign rs59794024 GRCh37 Chromosome 16, 1245062: 1245062
50 CACNA1H NM_021098.2(CACNA1H): c.390C> T (p.Ser130=) single nucleotide variant Benign rs59794024 GRCh38 Chromosome 16, 1195062: 1195062

Expression for Hyperaldosteronism, Familial, Type Iv

Search GEO for disease gene expression data for Hyperaldosteronism, Familial, Type Iv.

Pathways for Hyperaldosteronism, Familial, Type Iv

GO Terms for Hyperaldosteronism, Familial, Type Iv

Sources for Hyperaldosteronism, Familial, Type Iv

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....